Depression Drug Side Effects Including Body Weight, BP Fluctuations Differ Depending on Medication

• An extensive new study discovered that the unwanted effects of depression drugs vary substantially by drug.
• Certain pharmaceuticals caused reduced body weight, whereas others resulted in added mass.
• Pulse rate and arterial pressure additionally varied significantly across treatments.
• Individuals suffering from ongoing, serious, or worrisome unwanted effects ought to discuss with a medical provider.

Recent research has revealed that antidepressant medication unwanted effects may be more varied than previously thought.

The extensive investigation, published on the 21st of October, examined the impact of depression treatments on more than 58,000 participants within the initial eight weeks of starting medication.

The researchers studied 151 studies of 30 pharmaceuticals frequently employed to treat major depression. While not everyone experiences unwanted effects, several of the most common observed in the research were variations in body weight, blood pressure, and metabolic markers.

Researchers observed notable disparities across depression treatments. For example, an 60-day treatment period of agomelatine was connected with an typical decrease in mass of around 2.4 kg (about 5.3 lbs), whereas maprotiline users gained close to 2 kg in the same duration.

Additionally, notable changes in heart function: fluvoxamine often would decrease pulse rate, whereas nortriptyline increased it, creating a gap of about 21 heartbeats per minute across the two medications. Arterial pressure differed as well, with an 11 millimeters of mercury difference noted across nortriptyline and doxepin.

Clinical professionals commented that the investigation's findings are not novel or surprising to psychiatrists.

"We've long known that distinct antidepressants range in their impacts on body weight, BP, and further metabolic parameters," one expert explained.

"Nonetheless, what is remarkable about this research is the thorough, comparative assessment of these differences among a wide range of bodily measurements employing data from more than 58,000 participants," this professional added.

This research offers comprehensive evidence of the degree of adverse reactions, some of which are more frequent than different reactions. Typical depression drug side effects may comprise:

• stomach problems (nausea, loose stools, constipation)
• sexual dysfunction (reduced sex drive, inability to orgasm)
• weight changes (increase or reduction, depending on the medication)
• sleep disturbances (insomnia or sleepiness)
• mouth dryness, moisture, headache

At the same time, rarer but medically important unwanted effects may comprise:

• rises in BP or pulse rate (notably with serotonin-norepinephrine reuptake inhibitors and some tricyclics)
• low sodium (notably in elderly individuals, with selective serotonin reuptake inhibitors and SNRIs)
• increased liver enzymes
• Corrected QT interval prolongation (potential of arrhythmia, particularly with citalopram and certain tricyclic antidepressants)
• diminished feelings or indifference

"A key factor to note here is that there are multiple distinct categories of depression drugs, which lead to the varying adverse medication effects," a different specialist explained.

"Additionally, antidepressant medications can affect every individual variably, and negative effects can differ according to the specific drug, amount, and patient factors like metabolic rate or co-occurring conditions."

While some adverse reactions, such as variations in rest, hunger, or stamina, are reasonably frequent and frequently enhance as time passes, other effects may be less frequent or continuing.

Antidepressant medication unwanted effects may range in severity, which could warrant a change in your medication.

"A modification in antidepressant medication may be necessary if the individual encounters persistent or intolerable side effects that don't get better with passing days or management strategies," one specialist said.

"Additionally, if there is an development of new health problems that may be aggravated by the present treatment, such as hypertension, irregular heartbeat, or significant weight gain."

You may furthermore consider consulting with your healthcare provider regarding any absence of significant progress in depressive or anxiety-related signs after an adequate evaluation duration. The appropriate testing period is usually 4–8 weeks at a effective amount.

Individual preference is furthermore significant. Some people may prefer to prevent particular adverse reactions, including sexual problems or {weight gain|increased body weight|mass addition